Meplazumab

meplazumab · Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Meplazumab, covering 2021-04-09 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease [Phase 2]